BerGenBio AS's market cap is currently ―. The company's EPS TTM is $-0.033; its P/E ratio is -0.75; BerGenBio AS is scheduled to report earnings on May 29, 2024, and the estimated EPS forecast is

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	kr 66.54M	kr 55.34M	kr 0.00	kr 0.00	kr 0.00
Gross Profit	-	-	-	-	-
EBIT	kr 20.87M	kr 20.31M	kr -56.01M	kr -82.27M	kr -78.16M
EBITDA	kr 24.20M	kr 28.64M	kr -55.87M	kr -81.95M	kr -77.85M
Net Income Common Stockholders	kr 16.27M	kr 47.12M	kr -59.80M	kr -84.07M	kr -81.07M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	kr 0.00	kr 0.00	kr 225.07M	kr 292.14M	kr 367.83M
Total Assets	kr 8.02B	kr 6.46B	kr 235.52M	kr 306.03M	kr 380.60M
Total Debt	kr 407.83M	kr 278.37M	kr 0.00	kr 651.00K	kr 796.00K
Net Debt	kr 407.83M	kr 278.37M	kr -225.07M	kr -291.49M	kr -367.03M
Total Liabilities	kr 7.12B	kr 5.82B	kr 70.62M	kr 82.03M	kr 72.56M
Stockholders Equity	kr 896.40M	kr 646.66M	kr 164.90M	kr 224.00M	kr 308.04M
Cash Flow	-
Free Cash Flow	kr 4.35M	kr 11.87M	kr -65.83M	kr -70.69M	kr -74.20M
Operating Cash Flow	kr 4.68M	kr 21.63M	kr -65.83M	kr -70.69M	kr -74.20M
Investing Cash Flow	kr 289.88M	kr -18.03M	kr 778.00K	kr 445.00K	kr 85.00K
Financing Cash Flow	kr -106.36M	kr -22.13M	kr 0.00	kr -74.00K	kr 2.98M

Currency in NOK

BerGenBio AS Earnings and Revenue History

Income Statement >

BerGenBio AS Debt to Assets

Balance Sheet >

BerGenBio AS Cash Flow

Cash Flow >

BerGenBio AS Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing